{"id":"W150581942","doi":"10.1023/a:1026273509058","title":"The Treatment of De Novo Acromegalic Patients with Octreotide-LAR: Efficacy, Tolerability and Cardiovascular Effects","year":2003,"lang":"en","type":"article","venue":"Pituitary","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Acromegaly; Ejection fraction; Tolerability; Internal medicine; Somatostatin; Octreotide; Pegvisomant; Endocrinology; Gastroenterology; Cardiology; Hormone; Growth hormone; Heart failure; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000279067,0.0002310573,0.0007049153,0.0001279258,0.0001473671,0.0002127311,0.0001695213,0.0003441902,0.0009410622],"category_scores_gemma":[0.0004866885,0.0001154362,0.0002809088,0.000151151,0.0001604188,0.0002585459,0.00007783755,0.0007616654,0.0001616913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001592286,"about_ca_system_score_gemma":0.0002088668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005484808,"about_ca_topic_score_gemma":0.001506715,"domain_scores_codex":[0.9999039,0.00004511735,0.000008259706,0.000008127899,0.00001768468,0.00001698471],"domain_scores_gemma":[0.9997928,0.00009732776,0.00003853801,0.00001033699,0.00001094156,0.00005008485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1824776,0.004538128,0.07788026,0.0009084846,0.00125958,0.004941432,0.0004257971,0.002075525,0.2742531,0.0004425716,0.002652917,0.4481446],"study_design_scores_gemma":[0.03501678,0.2072586,0.6456025,0.0001498699,0.00198822,0.02306891,0.0006467159,0.006245883,0.06403033,0.0005148632,0.01534977,0.0001275371],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989655,0.008084626,0.0002619693,0.0002726231,0.00003428522,0.0000290158,0.0001279367,0.00002416545,0.001510313],"genre_scores_gemma":[0.9967453,0.002030172,0.0003210082,0.0001865219,0.00007142041,0.00001551365,0.0002014383,0.000005758953,0.0004227764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009410622,"threshold_uncertainty_score":0.003148198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005772736626530167,"score_gpt":0.2146667129679873,"score_spread":0.2088939763414571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}